Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
Phase of Trial: Phase II/III
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Ranolazine (Primary)
- Indications Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms RIMINI-Pilot
- 10 Jun 2017 Biomarkers information updated
- 10 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 23 May 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-000030-35).